Molecular mechanisms involved in inflammasome activation

Trends in Cell Biology

Volumn 19, Issue 9, 2009, Pages 455-464

  Bryant, Clare ^a   Fitzgerald, Katherine A ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MULTIPROTEIN COMPLEX; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; PROTEIN AIM2; PROTEIN NLRC4; PROTEIN NLRP1; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; CELL DEATH; CLINICAL TRIAL; CYTOKINE RELEASE; DISEASE ASSOCIATION; DRUG TARGETING; ENZYME ACTIVATION; GOUT; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFLAMMATORY DISEASE; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CASPASE 1; HUMANS; INFLAMMATION; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 69549119940     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2009.06.002     Document Type: Review

References (80)

1. Kawai T., and Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann. N. Y. Acad. Sci. 1143 (2008) 1-20
2. Meylan E., et al. Intracellular pattern recognition receptors in the host response. Nature 442 (2006) 39-44
3. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int. Immunol. 17 (2005) 1-14
4. Huysamen C., and Brown G.D. The fungal pattern recognition receptor, Dectin-1, and the associated cluster of C-type lectin-like receptors. FEMS Microbiol. Lett. 290 (2009) 121-128
5. Yoneyama M., and Fujita T. RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity. Cytokine Growth Factor Rev. 18 (2007) 545-551
6. Takaoka A., and Taniguchi T. Cytosolic DNA recognition for triggering innate immune responses. Adv. Drug. Deliv. Rev. 60 (2008) 847-857
7. Takaoka A., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448 (2007) 501-505
8. Burckstummer T., et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat. Immunol. 10 (2009) 266-272
9. Fernandes-Alnemri T., et al. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458 (2009) 509-513
10. Hornung V., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458 (2009) 514-518
11. Roberts T.L., et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323 (2009) 1057-1060
12. Martinon F., et al. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27 (2009) 229-265
13. Kono H., and Rock K.L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8 (2008) 279-289
14. Dinarello C.A. Interleukin-1beta. Crit. Care Med 33 (2005) S460-S462
15. Dinarello C.A. The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20 (2002) S1-S13
16. Hiscott J., et al. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol. Cell Biol. 13 (1993) 6231-6240
17. Heitmeier M.R., et al. Double-stranded RNA-induced inducible nitric-oxide synthase expression and interleukin-1 release by murine macrophages requires NF-kappaB activation. J. Biol. Chem. 273 (1998) 15301-15307
18. Martinon F., et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10 (2002) 417-426
19. Franchi L., et al. Function of Nod-like receptors in microbial recognition and host defense. Immunol. Rev. 227 (2009) 106-128
20. Siegel R.M. Caspases at the crossroads of immune-cell life and death. Nat. Rev. Immunol. 6 (2006) 308-317
21. McDermott M.F., and Tschopp J. From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases. Trends. Mol. Med. 13 (2007) 381-388
22. Masters S.L., et al. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu. Rev. Immunol. 27 (2009) 621-668
23. Martinon F., and Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends. Immunol. 26 (2005) 447-454
24. Faustin B., et al. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 25 (2007) 713-724
25. Boyden E.D., and Dietrich W.F. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 38 (2006) 240-244
26. Miao E.A., et al. TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Semin. Immunopathol. 29 (2007) 275-288
27. Lightfield K.L., et al. Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat. Immunol. 9 (2008) 1171-1178
28. Sun Y.H., et al. Injection of flagellin into the host cell cytosol by Salmonella enterica serotype Typhimurium. J. Biol. Chem. 282 (2007) 33897-33901
29. Agostini L., et al. NALP3 forms an IL-1βeta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20 (2004) 319-325
30. Franchi L., et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat. Immunol. 7 (2006) 576-582
31. Mariathasan S., et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430 (2004) 213-218
32. Miao E.A., et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat. Immunol. 7 (2006) 569-575
33. Suzuki T., et al. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog. 3 (2007) e111
34. Master S.S., et al. Mycobacterium tuberculosis prevents inflammasome activation. Cell Host. Microbe. 3 (2008) 224-232
35. Kanneganti T.D., et al. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 281 (2006) 36560-36568
36. Thomas P.G., et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30 (2009) 566-575
37. Allen I.C., et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30 (2009) 556-565
38. Ichinohe T., et al. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206 (2009) 79-87
39. Muruve D.A., et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452 (2008) 103-107
40. Gross O., et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459 (2009) 433-436
41. Mariathasan S., et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440 (2006) 228-232
42. Warren S.E., et al. Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection. J. Immunol. 180 (2008) 7558-7564
43. Kahlenberg J.M., et al. Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis. J. Immunol. 175 (2005) 7611-7622
44. Petrilli V., et al. The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 19 (2007) 615-622
45. Shi Y., et al. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425 (2003) 516-521
46. Halle A., et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9 (2008) 857-865
47. Dostert C., et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320 (2008) 674-677
48. Hornung V., et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9 (2008) 847-856
49. Ferrari D., et al. The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176 (2006) 3877-3883
50. Kanneganti T.D., et al. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26 (2007) 433-443
51. Pelegrin P., et al. P2X7 receptor differentially couples to distinct release pathways for IL-1βeta in mouse macrophage. J. Immunol. 180 (2008) 7147-7157
52. Pelegrin P., and Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J. 25 (2006) 5071-5082
53. Marina-Garcia N., et al. Pannexin-1-mediated intracellular delivery of muramyl dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of Nod2. J. Immunol. 180 (2008) 4050-4057
54. Hsu L.C., et al. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1βeta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 7803-7808
55. Franchi L., et al. Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria. J. Biol. Chem. 282 (2007) 18810-18818
56. Martinon F., et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440 (2006) 237-241
57. Sharp F.A., et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 870-875
58. Eisenbarth S.C., et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453 (2008) 1122-1126
59. Franchi L., and Nunez G. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1βeta secretion but dispensable for adjuvant activity. Eur. J. Immunol. 38 (2008) 2085-2089
60. Li H., et al. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181 (2008) 17-21
61. Guarda G., et al. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 460 (2009) 269-273
62. Lich J.D., and Ting J.P. Monarch-1/PYPAF7 and other CATERPILLER (CLR, NOD, NLR) proteins with negative regulatory functions. Microbes. Infect 9 (2007) 672-676
63. Lich J.D., et al. Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. J. Immunol. 178 (2007) 1256-1260
64. Williams K.L., et al. The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. J. Biol. Chem. 280 (2005) 39914-39924
65. Choubey D., et al. Cytoplasmic localization of the interferon-inducible protein that is encoded by the AIM2 (absent in melanoma) gene from the 200-gene family. FEBS Lett. 474 (2000) 38-42
66. Cresswell K.S., et al. Biochemical and growth regulatory activities of the HIN-200 family member and putative tumor suppressor protein, AIM2. Biochem. Biophys. Res. Commun 326 (2005) 417-424
67. Ting J.P., et al. NLRs at the intersection of cell death and immunity. Nat. Rev. Immunol. 8 (2008) 372-379
68. Kufer T.A., and Sansonetti P.J. Sensing of bacteria: NOD a lonely job. Curr. Opin. Microbiol. 10 (2007) 62-69
69. Bergsbaken T., et al. Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 7 (2009) 99-109
70. Dowds T.A., et al. Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem. Biophys. Res. Commun. 302 (2003) 575-580
71. Akhter A., et al. Caspase-7 activation by the Nlrc4/Ipaf inflammasome restricts Legionella pneumophila infection. PLoS Pathog. 5 (2009) e1000361
72. Lamkanfi M., et al. Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. Mol. Cell Proteomics 7 (2008) 2350-2363
73. Dowds T.A., et al. Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J. Biol. Chem. 279 (2004) 21924-21928
74. Jin Y., et al. NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 356 (2007) 1216-1225
75. So A., et al. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis. Res. Ther. 9 (2007) R28
76. Mossman B.T., and Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am. J. Respir. Crit. Care Med. 157 (1998) 1666-1680
77. Cassel S.L., et al. The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 9035-9040
78. Kawane K., et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443 (2006) 998-1002
79. Nagata S. Autoimmune diseases caused by defects in clearing dead cells and nuclei expelled from erythroid precursors. Immunol. Rev. 220 (2007) 237-250
80. Kalliolias G.D., and Liossis S.N. The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis. Expert. Opin. Investig. Drugs 17 (2008) 349-359